These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2164400)
1. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Petersen J; Rhodes G; Roudier J; Vaughan JH Arthritis Rheum; 1990 Jul; 33(7):993-1000. PubMed ID: 2164400 [TBL] [Abstract][Full Text] [Related]
2. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1. Baboonian C; Halliday D; Venables PJ; Pawlowski T; Millman G; Maini RN Rheumatol Int; 1989; 9(3-5):161-6. PubMed ID: 2481875 [TBL] [Abstract][Full Text] [Related]
3. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130 [TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. Fox R; Sportsman R; Rhodes G; Luka J; Pearson G; Vaughan J J Clin Invest; 1986 May; 77(5):1539-47. PubMed ID: 2422209 [TBL] [Abstract][Full Text] [Related]
5. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Sculley TB; Pope JH; Hazelton RA Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369 [TBL] [Abstract][Full Text] [Related]
6. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
7. Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Baboonian C; Venables PJ; Williams DG; Williams RO; Maini RN Ann Rheum Dis; 1991 Nov; 50(11):772-5. PubMed ID: 1722966 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Sabbatini A; Bombardieri S; Migliorini P Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. Kouri T; Petersen J; Rhodes G; Aho K; Palosuo T; Heliövaara M; Isomäki H; von Essen R; Vaughan JH J Rheumatol; 1990 Nov; 17(11):1442-9. PubMed ID: 2177109 [TBL] [Abstract][Full Text] [Related]
10. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1. Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. Alspaugh MA; Henle G; Lennette ET; Henle W J Clin Invest; 1981 Apr; 67(4):1134-40. PubMed ID: 6259211 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. Rhodes G; Rumpold H; Kurki P; Patrick KM; Carson DA; Vaughan JH J Exp Med; 1987 Apr; 165(4):1026-40. PubMed ID: 2435830 [TBL] [Abstract][Full Text] [Related]
14. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Incaprera M; Rindi L; Bazzichi A; Garzelli C Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491 [TBL] [Abstract][Full Text] [Related]
16. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. McClain MT; Rapp EC; Harley JB; James JA J Med Virol; 2003 Jun; 70(2):253-7. PubMed ID: 12696112 [TBL] [Abstract][Full Text] [Related]
18. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. Yokochi T; Yanagawa A; Kimura Y; Mizushima Y J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505 [TBL] [Abstract][Full Text] [Related]
19. Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1. Venables PJ; Pawlowski T; Mumford PA; Brown C; Crawford DH; Maini RN Ann Rheum Dis; 1988 Apr; 47(4):270-9. PubMed ID: 2452607 [TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Kitagawa H; Iho S; Yokochi T; Hoshino T Immunol Lett; 1988 Mar; 17(3):249-52. PubMed ID: 2836302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]